Greenbrook TMS Inc. (GBNH)
Stock analysis · NASDAQ · Healthcare · Medical - Care Facilities
Greenbrook TMS Inc. (GBNH) is a publicly traded company in the Healthcare sector. Latest price: $0.12. Market cap $5.52M. Trailing PE -0.03. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Earnings
Proprietary Signals
About Greenbrook TMS Inc.
Greenbrook TMS Inc., and its associated entities, oversees and runs a broad array of outpatient mental healthcare centers throughout the United States. These specialized clinics primarily deliver transcranial magnetic stimulation (TMS) therapy, an FDA-approved, non-surgical treatment effective for major depressive disorder and various other mental health conditions. Additionally, they provide a suite of related psychiatric services. By the close of 2021, the company's operational reach extended to 149 TMS centers (94 wholly owned and 55 other facilities) dispersed across 17 U.S. states. These states include Virginia, Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.
Valuation
| P/E (TTM) | -0.03× |
|---|---|
| P/S (TTM) | 0.08× |
| P/B | -0.10× |
| P/FCF (TTM) | -0.42× |
| EV / EBITDA | -5.59× |
| EV / Sales | 1.61× |
| Earnings Yield | -3088.23% |
| Free Cash Flow Yield | -240.04% |
Fundamentals
| Enterprise Value | $111.43M |
|---|---|
| Revenue (TTM) | $69.10M |
| Net Income (TTM) | -$170.40M |
| Free Cash Flow (TTM) | -$1.13M |
| Net Debt | $105.91M |
| Working Capital | -$18.10M |
| Gross Margin | 8.77% |
| Operating Margin | -42.60% |
| Net Margin | -125.48% |
| Return on Equity | 1574.36% |
| Return on Invested Capital | -38.26% |
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap